Cloned Cat Fetches $50,000

The first cloned cat has sold for $50,000 at auction.

Bioject Medical Technologies reported this morning that it received milestone payments during its fourth quarter from Merial.

The payments are part of a collaboration agreement that allows Merial to use a modified version of Bioject’s Vitajet needle-free delivery system for the companion animal market, Bioject reports.

One payment was based on regulatory approval of a vaccine developed by Merial and designed to be administered with the needle-free system. Bioject also received a second milestone payment during the quarter following the delivery of 10 prototype devices to Merial.

"We are looking forward to the commercial launch of the product for the companion animal market during the first quarter of 2005," said Jim O’Shea, chairman and chief executive officer of Bioject.


Leave a Comment



Sign-up for your account with Veterinary Practice News Canada. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News Canada.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, digital editions of the magazine, a survey now and then, and offers to the veterinarian industry*).

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.